Hyundai Bioscience announced positive phase 2 clinical study results of the global blockbuster candidate for the COVID-19 antiviral drug ...Middle East

- Hyundai Bioscience announcing the receipt of the phase 2 clinical study report of XaftyTM and its plans for the emergency use authorization - Planning fast track process in oversea countries to enter the global market SEOUL, South Korea, May 2, 2023 /PRNewswire/ -- Hyundai Bioscience...

Read More Details
Finally We wish PressBee provided you with enough information of ( Hyundai Bioscience announced positive phase 2 clinical study results of the global blockbuster candidate for the COVID-19 antiviral drug )

Also on site :

• 'General Hospital' Fans Brace for 'Slap in the Face' amid Star's Return
• Billionaire Telegram founder leaves his $14 billion fortune to the 100+ children he’s fathered—which means $132 million for each lucky Gen Alpha kid
• Sandra Oh Makes a Bold Statement About Whether She’ll Return to 'Grey’s Anatomy'